Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mechanisms of Multidrug Resistance in Cancer Chemotherapy
Karol Bukowski, Mateusz Kciuk, Renata Kontek
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 9, pp. 3233-3233
Open Access | Times Cited: 1305

Showing 1-25 of 1305 citing articles:

Small molecules in targeted cancer therapy: advances, challenges, and future perspectives
Lei Zhong, Yueshan Li, Liang Xiong, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 1176
PI3K/AKT pathway as a key link modulates the multidrug resistance of cancers
Rui Liu, Youwen Chen, Guangzhi Liu, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 9
Open Access | Times Cited: 649
Regulated cell death (RCD) in cancer: key pathways and targeted therapies
Peng Fu, Minru Liao, Rui Qin, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 502
The Hippo signalling pathway and its implications in human health and diseases
Minyang Fu, Yuan Hu, Tianxia Lan, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 342
Doxorubicin—An Agent with Multiple Mechanisms of Anticancer Activity
Mateusz Kciuk, Adrianna Gielecińska, Somdutt Mujwar, et al.
Cells (2023) Vol. 12, Iss. 4, pp. 659-659
Open Access | Times Cited: 316
Apoptosis Deregulation and the Development of Cancer Multi-Drug Resistance
Christiana M. Neophytou, Ioannis P. Trougakos, Nuray Erin, et al.
Cancers (2021) Vol. 13, Iss. 17, pp. 4363-4363
Open Access | Times Cited: 249
Therapy resistance: opportunities created by adaptive responses to targeted therapies in cancer
Marilyne Labrie, Joan S. Brugge, Gordon B. Mills, et al.
Nature reviews. Cancer (2022) Vol. 22, Iss. 6, pp. 323-339
Open Access | Times Cited: 227
Irinotecan—Still an Important Player in Cancer Chemotherapy: A Comprehensive Overview
Mateusz Kciuk, Beata Marciniak, Renata Kontek
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 14, pp. 4919-4919
Open Access | Times Cited: 189
Battling Chemoresistance in Cancer: Root Causes and Strategies to Uproot Them
Alisha Ramos, Samira Sadeghi, Hossein Tabatabaeian
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9451-9451
Open Access | Times Cited: 181
Nano-drug co-delivery system of natural active ingredients and chemotherapy drugs for cancer treatment: a review
Bingqian Li, Huili Shao, Lei Gao, et al.
Drug Delivery (2022) Vol. 29, Iss. 1, pp. 2130-2161
Open Access | Times Cited: 173
Overcoming cancer chemotherapy resistance by the induction of ferroptosis
Yumin Wang, Xiaorui Wu, Ren Zhao, et al.
Drug Resistance Updates (2022) Vol. 66, pp. 100916-100916
Closed Access | Times Cited: 171
Therapeutic strategies to overcome taxane resistance in cancer
Tuyelee Das, Uttpal Anand, Swaroop Kumar Pandey, et al.
Drug Resistance Updates (2021) Vol. 55, pp. 100754-100754
Closed Access | Times Cited: 160
Potential mechanisms of quercetin in cancer prevention: focus on cellular and molecular targets
Parina Asgharian, Abbas Pirpour Tazekand, Kamran Hosseini, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 160
Targeting Drug Chemo-Resistance in Cancer Using Natural Products
Wamidh H. Talib, Ahmad R. Alsayed, Muna Barakat, et al.
Biomedicines (2021) Vol. 9, Iss. 10, pp. 1353-1353
Open Access | Times Cited: 141
Overcoming Cancer Multi-drug Resistance (MDR): Reasons, mechanisms, nanotherapeutic solutions, and challenges
Chunyan Duan, Mingjia Yu, Jiyuan Xu, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114643-114643
Open Access | Times Cited: 139
Theranostic Fluorescent Probes
Amit Sharma, Peter Verwilst, Mingle Li, et al.
Chemical Reviews (2024) Vol. 124, Iss. 5, pp. 2699-2804
Open Access | Times Cited: 139
The Promise of Nanotechnology in Personalized Medicine
Maha Al‐Ghamdi, Antonino N. Fallica, Nicola Filippo Virzì, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 5, pp. 673-673
Open Access | Times Cited: 138
The role of polyphenols in overcoming cancer drug resistance: a comprehensive review
Parisa Maleki Dana, Fatemeh Sadoughi, Zatollah Asemi, et al.
Cellular & Molecular Biology Letters (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 133
Understanding and targeting resistance mechanisms in cancer
Zi‐Ning Lei, Tian Qin, Qiu‐Xu Teng, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 120
Advances and Limitations of Antibody Drug Conjugates for Cancer
Candice Maria Mckertish, Veysel Kayser
Biomedicines (2021) Vol. 9, Iss. 8, pp. 872-872
Open Access | Times Cited: 113
Targeted Delivery of Drugs and Genes Using Polymer Nanocarriers for Cancer Therapy
Wentao Xia, Zixuan Tao, Bin Zhu, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9118-9118
Open Access | Times Cited: 113
Mutual regulation between N6-methyladenosine (m6A) modification and circular RNAs in cancer: impacts on therapeutic resistance
Hong Lin, Di Wang, Pinghan Wang, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 87
Chemotherapy: how to reduce its adverse effects while maintaining the potency?
Brianna Brianna, Sau Har Lee
Medical Oncology (2023) Vol. 40, Iss. 3
Closed Access | Times Cited: 86
Extracellular‐Vesicle‐Based Drug Delivery Systems for Enhanced Antitumor Therapies through Modulating the Cancer‐Immunity Cycle
Tuying Yong, Zhaohan Wei, Lu Gan, et al.
Advanced Materials (2022) Vol. 34, Iss. 52
Closed Access | Times Cited: 85
Targeted Therapy and Mechanisms of Drug Resistance in Breast Cancer
Briana Kinnel, Santosh Kumar Singh, Gabriela Oprea‐Ilies, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1320-1320
Open Access | Times Cited: 79
Page 1 - Next Page

Scroll to top